Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Boron Nitrogen Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110746448A introduces a novel chiral 1,2-ethylenediamine boron-nitrogen ligand. This technology enables cost reduction in asymmetric catalysis manufacturing and ensures high-purity pharmaceutical intermediates.